Roadmap

From prototype to CE marking

Our device is expected to be a Class IIb medical device under the EU Medical Device Regulation (MDR). This is the path we have planned to reach the market, milestone by milestone.

ProductClinicalRegulatory & qualityIntellectual propertyAchieved
2023–25
AchievedINNVAL 23/18

Research project at IFCA

Silicon carbide diodes validated as suitable for HDR brachytherapy, with measurements on a real ¹⁹²Ir source at HUMV and a favourable ethics committee opinion.

Achieved2025

UCem entrepreneurship award

University of Cantabria award for the business project.

2026
Achieved2026

Company founded and first flexible boards

Particle Care Technologies S.L. is incorporated at CDTUC. Independent patentability report and selection for TOP101 Spain Up Nation.

We are here
Q4 2026
2026
ProductQ4 2026 – Q2 2027In progress

P1Probe consolidation

A sealed, stable probe that gives repeatable measurements.

Regulatory & qualityQ4 2026 – Q1 2027

R1MDR classification and regulatory roadmap

Formal classification report, checked with a notified body.

MDR Art. 51 · Annex VIII
2027
ProductQ1 2027 – Q2 2028

P2Readout electronics and complete demonstrator

Developed with Tekniker and refined through a measurement campaign at HUMV.

Regulatory & qualityQ1 – Q4 2027

R2Quality and risk management

Quality management system and risk management file.

ISO 13485 · ISO 14971
Intellectual propertyQ2 2027

European patent application

Priority filing with the European Patent Office.

ClinicalQ3 2027 – Q1 2028

C1Validation at Hospital Virtual Valdecilla

On an anthropomorphic phantom we reproduce a correct and an incorrect treatment, and check that the system tells them apart, with no risk to patients.

2028
Intellectual propertyQ2 2028

International PCT application

Within 12 months of the priority date.

ClinicalQ2 2028 – Q2 2029

C2Patient study at HUMV

Measured dose compared with planned dose in real treatments, and impact on the patient workflow. The basis of the clinical evaluation report.

ProductQ3 2028 – Q2 2029

P3Design freeze

Embedded software and usability verified.

IEC 62304 · IEC 62366-1
2029
ProductQ3 2029 – Q1 2030

P4Electrical safety and EMC testing

Tests in an accredited laboratory.

IEC 60601-1 · IEC 60601-1-2
Intellectual propertyQ4 2029

National and regional phases

Protection in Europe and the United States.

2030
Regulatory & qualityQ1 – Q2 2030

R3Technical documentation

Complete technical file.

MDR Annexes II–III
Regulatory & qualityQ3 2030 – Q1 2031

R4Notified body assessment

Audit of the quality system and review of the technical file.

MDR Annex IX
2031
Regulatory & qualityQ2 – Q4 2031Final milestone

R5CE marking

CE certificate, EU declaration of conformity, UDI and EUDAMED registration. The device can be sold in the European Union.

MDR Art. 20 · 27 · 29
2032+
ProductFrom 2032

Digital integration

Integration with treatment planning systems and afterloaders, followed by AI-assisted fast Monte Carlo plan optimisation.

Dates are estimates and may change as the project progresses. Milestone codes: P = product, C = clinical, R = regulatory.